EW Q4 2020 Earnings — Edwards Lifesciences Corporation Revenue & Financial Results | Market Cap Arena

EWEdwards Lifesciences Corporation

$50B

Q4 2020 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$1.2B+1.5% YoY

Gross Profit

$897M75.2% margin

Operating Income

$362M30.4% margin

Net Income

$310M26.0% margin

EPS (Diluted)

$0.49

QoQ Revenue Growth

+4.5%

Cash Flow

Operating Cash Flow

$400M

Free Cash Flow

$287M

Stock-Based Comp.

$21M

Balance Sheet

Total Assets

$7.2B

Total Liabilities

$2.7B

Stockholders' Equity

$4.6B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$1.2B	+1.5%
Gross Profit	$897M	$879M	+2.0%
Operating Income	$362M	$337M	+7.5%
Net Income	$310M	$280M	+10.5%

Revenue Segments

Transcatheter Heart Valves

$776M65%

Surgical Heart Valve Therapy

$204M17%

Critical Care

$198M17%

Transcatheter Mitral And Tricuspid Therapies

$13M1%

Geographic Segments

UNITED STATES

$671M56%

Europe

$266M22%

JAPAN

$129M11%

Rest of World

$125M11%